Skip to main content
Erschienen in:

01.08.2016 | CME

Antiarrhythmische Therapie im Notarztwagen

verfasst von: Dr. J. C. Karcher, K. Kouraki, U. Zeymer

Erschienen in: Notfall + Rettungsmedizin | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

In Akutsituationen im Rettungsdienst sind Diagnose und Therapie von Herzrhythmusstörungen an einfachen und sicher erkennbaren Kriterien auszurichten. Neben Anamnese und körperlichem Untersuchungsbefund ist v. a. das 12-Kanal-Oberflächen-EKG entscheidend. Die Einteilung in regelmäßige sowie unregelmäßige Schmal- und Breitkomplextachykardien hilft bei der Zuordnung der Herzrhythmusstörung und ist die Grundlage der medikamentösen Therapie. Die elektrische Therapie (Kardioversion/Defibrillation) und die medikamentöse antiarrhythmische Therapie sind maßgeblich in der Behandlung der häufig vital gefährdeten Patienten. Im Rettungsdienst kann die antiarrhythmische Medikation auf wenige sinnvoll einsetzbare Substanzen reduziert werden. Die vorliegende Arbeit beruht auf den aktuellen Therapieempfehlungen des European Resuscitation Council (2015), der Europäischen Gesellschaft für Kardiologie, den amerikanischen Leitlinien (American College of Cardiology, American Heart Association) und einer Literaturauswahl der Autoren.
Literatur
1.
Zurück zum Zitat Heinz G (2008) Arrhythmias in the ICU: what do we know? Am J Respir Crit Care Med 178(1):1–2. doi:10.1164/rccm.200804-554EDCrossRefPubMed Heinz G (2008) Arrhythmias in the ICU: what do we know? Am J Respir Crit Care Med 178(1):1–2. doi:10.1164/rccm.200804-554EDCrossRefPubMed
2.
Zurück zum Zitat Xie B, Thakur RK, Shah CP, Hoon VK (1998) Clinical differentiation of narrow QRS complex tachycardias. Emerg Med Clin North Am 16(2):295–330CrossRefPubMed Xie B, Thakur RK, Shah CP, Hoon VK (1998) Clinical differentiation of narrow QRS complex tachycardias. Emerg Med Clin North Am 16(2):295–330CrossRefPubMed
3.
Zurück zum Zitat Soar J, Callaway CW, Aibiki M, Bottiger BW, Brooks SC, Deakin CD, Donnino MW, Drajer S, Kloeck W, Morley PT, Morrison LJ, Neumar RW, Nicholson TC, Nolan JP, Okada K, O’Neil BJ, Paiva EF, Parr MJ, Wang TL, Witt J, Advanced Life Support Chapter C (2015) Part 4: advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation 95:e71–e120. doi:10.1016/j.resuscitation.2015.07.042CrossRefPubMed Soar J, Callaway CW, Aibiki M, Bottiger BW, Brooks SC, Deakin CD, Donnino MW, Drajer S, Kloeck W, Morley PT, Morrison LJ, Neumar RW, Nicholson TC, Nolan JP, Okada K, O’Neil BJ, Paiva EF, Parr MJ, Wang TL, Witt J, Advanced Life Support Chapter C (2015) Part 4: advanced life support: 2015 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation 95:e71–e120. doi:10.1016/j.resuscitation.2015.07.042CrossRefPubMed
4.
Zurück zum Zitat American College of Cardiology F, American Heart A, European Society of C, Heart Rhythm S, Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS (2013) Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 127(18):1916–1926. doi:10.1161/CIR.0b013e318290826dCrossRef American College of Cardiology F, American Heart A, European Society of C, Heart Rhythm S, Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS (2013) Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation 127(18):1916–1926. doi:10.1161/CIR.0b013e318290826dCrossRef
5.
Zurück zum Zitat Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, Estes NA 3rd, Field ME, Goldberger ZD, Hammill SC, Indik JH, Lindsay BD, Olshansky B, Russo AM, Shen WK, Tracy CM, Al-Khatib SM (2015) 2015 ACC/AHA/HRS guideline for the management of adult patients with Supraventricular tachycardia: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. doi:10.1016/j.jacc.2015.08.856PubMedCentral Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, Estes NA 3rd, Field ME, Goldberger ZD, Hammill SC, Indik JH, Lindsay BD, Olshansky B, Russo AM, Shen WK, Tracy CM, Al-Khatib SM (2015) 2015 ACC/AHA/HRS guideline for the management of adult patients with Supraventricular tachycardia: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. doi:10.1016/j.jacc.2015.08.856PubMedCentral
6.
Zurück zum Zitat Rankin AC, Brooks R, Ruskin JN, McGovern BA (1992) Adenosine and the treatment of supraventricular tachycardia. Am J Med 92(6):655–664CrossRefPubMed Rankin AC, Brooks R, Ruskin JN, McGovern BA (1992) Adenosine and the treatment of supraventricular tachycardia. Am J Med 92(6):655–664CrossRefPubMed
7.
Zurück zum Zitat Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. doi:10.1093/eurheartj/ehv316 Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. doi:10.1093/eurheartj/ehv316
8.
Zurück zum Zitat Huikuri HV, Castellanos A, Myerburg RJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345(20):1473–1482. doi:10.1056/NEJMra000650CrossRefPubMed Huikuri HV, Castellanos A, Myerburg RJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345(20):1473–1482. doi:10.1056/NEJMra000650CrossRefPubMed
9.
Zurück zum Zitat Miranda CC, Newton MC (2001) Successful defibrillation in the prone position. Br J Anaesth 87(6):937–938CrossRefPubMed Miranda CC, Newton MC (2001) Successful defibrillation in the prone position. Br J Anaesth 87(6):937–938CrossRefPubMed
10.
Zurück zum Zitat Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A (2002) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346(12):884–890. doi:10.1056/NEJMoa013029CrossRefPubMed Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A (2002) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346(12):884–890. doi:10.1056/NEJMoa013029CrossRefPubMed
11.
Zurück zum Zitat deSouza IS, Martindale JL, Sinert R (2015) Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review. Emerg Med J 32(2):161–167. doi:10.1136/emermed-2013-202973CrossRefPubMed deSouza IS, Martindale JL, Sinert R (2015) Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review. Emerg Med J 32(2):161–167. doi:10.1136/emermed-2013-202973CrossRefPubMed
12.
Zurück zum Zitat Ecc Committee S, Task Forces of the American Heart A (2005) 2005 american heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112(24 Suppl):IV1–203. doi:10.1161/CIRCULATIONAHA.105.166550 Ecc Committee S, Task Forces of the American Heart A (2005) 2005 american heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 112(24 Suppl):IV1–203. doi:10.1161/CIRCULATIONAHA.105.166550
13.
Zurück zum Zitat Allegra J, Lavery R, Cody R, Birnbaum G, Brennan J, Hartman A, Horowitz M, Nashed A, Yablonski M (2001) Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 49(3):245–249CrossRefPubMed Allegra J, Lavery R, Cody R, Birnbaum G, Brennan J, Hartman A, Horowitz M, Nashed A, Yablonski M (2001) Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 49(3):245–249CrossRefPubMed
14.
Zurück zum Zitat Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T (1999) Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341(12):871–878. doi:10.1056/NEJM199909163411203CrossRefPubMed Kudenchuk PJ, Cobb LA, Copass MK, Cummins RO, Doherty AM, Fahrenbruch CE, Hallstrom AP, Murray WA, Olsufka M, Walsh T (1999) Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341(12):871–878. doi:10.1056/NEJM199909163411203CrossRefPubMed
15.
Zurück zum Zitat Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A, Holmberg S (1995) Adrenaline in out-of-hospital ventricular fibrillation. Does it make any difference? Resuscitation 29(3):195–201CrossRefPubMed Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A, Holmberg S (1995) Adrenaline in out-of-hospital ventricular fibrillation. Does it make any difference? Resuscitation 29(3):195–201CrossRefPubMed
16.
Zurück zum Zitat Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L (2009) Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA 302(20):2222–2229. doi:10.1001/jama.2009.1729CrossRefPubMed Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L (2009) Intravenous drug administration during out-of-hospital cardiac arrest: a randomized trial. JAMA 302(20):2222–2229. doi:10.1001/jama.2009.1729CrossRefPubMed
17.
Zurück zum Zitat Chow T, Galvin J, McGovern B (1998) Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 82(4A):58I–62ICrossRefPubMed Chow T, Galvin J, McGovern B (1998) Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 82(4A):58I–62ICrossRefPubMed
Metadaten
Titel
Antiarrhythmische Therapie im Notarztwagen
verfasst von
Dr. J. C. Karcher
K. Kouraki
U. Zeymer
Publikationsdatum
01.08.2016
Verlag
Springer Medizin
Erschienen in
Notfall + Rettungsmedizin / Ausgabe 5/2016
Print ISSN: 1434-6222
Elektronische ISSN: 1436-0578
DOI
https://doi.org/10.1007/s10049-016-0195-0

Weitere Artikel der Ausgabe 5/2016

Notfall + Rettungsmedizin 5/2016 Zur Ausgabe

Mitteilungen des DBRD

Mitteilungen des DBRD

Mitteilungen des GRC

Mitteilungen des GRC